Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder

OBJECTIVE: We investigated the effects of duloxetine on the plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor (BDNF) in 64 patients with major depressive disorder (MDD). METHODS: Major depressive episode was diagnosed using the Structured Clinical Interview for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Atake, Kiyokazu, Yoshimura, Reiji, Hori, Hikaru, Katsuki, Asuka, Ikenouchi-Sugita, Atsuko, Umene-Nakano, Wakako, Nakamura, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022764/
https://www.ncbi.nlm.nih.gov/pubmed/24851119
http://dx.doi.org/10.9758/cpn.2014.12.1.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022764/
https://www.ncbi.nlm.nih.gov/pubmed/24851119
http://dx.doi.org/10.9758/cpn.2014.12.1.37

Ejemplares similares